Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

May 06 • 04:00PM ET

539.73

+37.26 7.42 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: GILD AKRO VKTX NBIX ENTA SLDB LXRX TSHA NBP RDHL

| Held by: VTI VB IWM VBK VXF XBI IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.80	Insider Own	9.14%	Shs Outstand	23.04M	Perf Week	4.08%
Market Cap	12.38B	Forward P/E	49.37	EPS next Y	10.93	Insider Trans	-5.95%	Shs Float	20.84M	Perf Month	5.44%
Enterprise Value	11.91B	PEG	-	EPS next Q	-1.97	Inst Own	103.09%	Short Float	19.26%	Perf Quarter	12.77%
Income	-309.44M	P/S	10.93	EPS this Y	54.69%	Inst Trans	1.33%	Short Ratio	11.50	Perf Half Y	30.89%
Sales	1.13B	P/B	22.88	EPS next Y	287.73%	ROA	-27.83%	Short Interest	4.01M	Perf YTD	-7.32%
Book/sh	23.59	P/C	15.14	EPS next 5Y	-	ROE	-49.35%	52W High	615.00 -12.24%	Perf Year	82.88%
Cash/sh	35.66	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-34.80%	52W Low	265.00 103.67%	Perf 3Y	76.17%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	92.94%	Volatility	4.26% 3.42%	Perf 5Y	325.96%
Dividend TTM	-	EV/Sales	10.52	EPS Y/Y TTM	41.81%	Oper. Margin	-27.68%	ATR (14)	21.47	Perf 10Y	3756.18%
Dividend Ex-Date	-	Quick Ratio	3.16	Sales Y/Y TTM	256.82%	Profit Margin	-27.32%	RSI (14)	61.23	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	3.50	EPS Q/Q	1.93%	SMA20	3.47%	Beta	-1.06	Target Price	673.87
Payout	-	Debt/Eq	0.64	Sales Q/Q	126.84%	SMA50	10.73%	Rel Volume	1.65	Prev Close	502.47
Employees	915	LT Debt/Eq	0.64	Earnings	May 06 BMO	SMA200	14.38%	Avg Volume	349.06K	Price	539.73
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	23.16% 3.42%	Trades		Volume	569,273	Change	7.42%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)